Last updated: February 20, 2026
What is NDC 00472-0478?
NDC 00472-0478 corresponds to a specific drug product registered in the National Drug Code (NDC) database. This code identifies a drug's manufacturer, drug formulation, and packaging. It is critical to verify the actual drug name, which, based on the NDC prefix, indicates it originates from the organization with manufacturer code 472. Exact product details—such as active ingredient, dosage, and therapeutic class—are necessary to conduct an accurate market analysis.
(Note: For this report, assume the product is a branded or generic medication within a well-defined therapeutic class.)
Market Landscape
Product Type and Therapeutic Area
- The drug's classification influences market size, competition, and pricing. For example, if it is a commonly prescribed medication in a large therapeutic area like cardiology, the market potential is higher.
- The presence of branded equivalents or generics affects pricing and market share.
Regulatory Status
- Approval date, expiration of exclusivity, or patent protection impact market entry and pricing.
- If the drug is approved by the FDA but pending patent expiration, generic competition might influence pricing.
Competition
- The number of approved alternatives within the same therapeutic class impacts market share.
- Patent protections extend exclusivity, delaying generic competition, which typically leads to higher prices.
Market Size
- Prescriptions per year, overall prevalence of the condition treated, and payer coverage influence revenue estimates.
- The drug's indication prevalence affects sales volume projections.
Pricing Factors
Current Pricing Data
- Wholesale Acquisition Cost (WAC): The average price paid by wholesalers to manufacturers.
- Average Wholesale Price (AWP): Published price used as a benchmark, often marked up for retail.
- National Average Drug Acquisition Cost (NADAC): Reflects actual purchase prices paid by retail pharmacies.
Historical Pricing Trends
- Prices for similar drugs in the same class have shown fluctuations based on patent status, competitor entry, and market penetration.
- Generic entry typically reduces brand prices by 50-90% within 1-2 years.
Influencing Variables
- Brand versus generic status.
- Distribution channels: hospital outpatient, retail pharmacy, specialty pharmacy.
- Insurance coverage and formulary placement.
Price Projections
Short-Term (Next 1-2 Years)
- For a brand-name drug with patent protection, prices may remain stable or increase 3-5% annually, aligned with inflation and demand.
- In markets where biosimilar or generic competition is imminent, prices could decrease by 20-50%.
Long-Term (3-5 Years)
- If patent protections expire, expect significant price erosion—possibly 50% or more.
- Market entry of generics/biosimilars can accelerate price declines, especially if they capture substantial market share.
Assumptions
- Continued market demand based on current prevalence.
- No major regulatory changes.
- Competitive landscape remains unchanged.
Model Table: Price Trends (Sample)
| Year |
Estimated Average Price (USD) |
Source/Methodology |
| 2023 |
$X (current WAC) |
Based on latest WAC data |
| 2024 |
$X + 3-5% |
Price inflation estimate |
| 2025 |
$X + 3-5% or -50% if generics enter |
Market competition impact |
(Note: Exact current prices require access to proprietary databases, such as RED BOOK or publicly available sources.)
Key Market Drivers Identified
- Patent patent expiration date and timing of biosimilar/generic launch.
- Coverage policies from Medicare, Medicaid, and private insurers.
- Prescriber and patient preferences.
- Pricing transparency initiatives and value-based contracting.
Conclusion
NDC 00472-0478's market prospects depend on its current patent status, therapeutic class size, and competitive landscape. Prices are projected to stabilize or slightly increase in the near term unless patent expiration or competition occurs. Long-term, prices may decline substantially if generic versions enter the market.
Key Takeaways
- Accurate product identification is required for precise market and price analysis.
- Market size and competition significantly influence price trajectories.
- Patent status and regulatory landscape govern short-term and long-term pricing.
- Price declines of 50% or more are typical upon generic entry after patent expiry.
- Prescriber and payer policies can modify these projections.
FAQs
-
What primary factors influence drug pricing?
Patent protection, competition, manufacturing costs, payer policies, and market demand.
-
How does patent expiry impact prices?
Generic or biosimilar entry usually causes prices to decrease by 50-90% within two years.
-
What data sources are used for price projections?
WAC, AWP, NADAC, historical price trends from industry reports, and market studies.
-
Can price trends vary regionally?
Yes. State and payer-specific policies, formularies, and market penetration influence local prices.
-
How quickly do generics affect pricing?
Price reductions can start within months of generic approval, reaching significant levels over 1-2 years.
References
[1] IQVIA. (2022). Market Trends and Pricing Data.
[2] U.S. Food and Drug Administration. (2022). Drug Approvals and Patent Data.
[3] Red Book. (2022). Average Wholesale Price and Wholesale Acquisition Cost Data.
[4] Centers for Medicare & Medicaid Services. (2022). Drug Pricing and Reimbursement Policies.
[5] SSR Health. (2022). Pricing Trends and Patent Expiry Analysis.
